Randomized control study on effect and safety in patients with type2 diabetes between patients who keep on using current amount of SU and patients who decrease current amount of SU in half : JDDM multi-center study

Randomized control study on effect and safety in patients with type2 diabetes between patients who keep on using current amount of SU and patients who decrease current amount of SU in half : JDDM multi-center study - Randomized control study on effect and safety in patients with type2 diabetes between patients who keep on using current amount of SU and patients who decrease current amount of SU in half : JDDM multi-center study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000008992

Enrollment

200

Registered

2012-10-01

Start date

2012-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type2 diabetes

Interventions

Group 1 : Decreases the amount of SU in half and observes 3 months period. Group 2 : Keeps on using the amount of SU and observes 3 months period.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with type 2 diabetes who are their age between 18 and 79. 2. Patients who continues to use SU at least three months. 3. Patients who continues their HbA1c below 7.4% at least three months. 4. Patients who can get written informed consent before enrolling the study.

Exclusion criteria

Exclusion criteria: 1. Patients having asymptomatic hypoglycemia or serious hypoglycemia. 2. Patients having their GOT higher than 80 IU/L or having their GPT higher than 80 IU/L. 3. Patients having their CRE higher than 1.7mg/dL. 4. Patients having vicious tumor or having a career of vicious tumor and a possibility to act up it. 5. Patients enrolling other clinical trials. 6. Patients receiving insulin therapy within 12 weeks. 7. Patients receiving steroid therapy entire body or planing to receive it in near future. 8. Patients who identified as improper by Drs

Design outcomes

Primary

Measure	Time frame
Changes in glycemic control among two groups	—

Secondary

Measure	Time frame
Changes in body weight among two groups	—

Countries

Japan

Contacts

Public ContactYoshio Kurihara

Kurihara internal medicine Director of the clinic

ykuri@yg7.so-net.ne.jp011-892-3522

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026